Costco Drops Abortion Pill Following AMAC Action Pressure Campaign

AMAC members have helped secure another significant win for grassroots conservatives and the pro-life movement as Costco has confirmed it will not stock or dispense the abortion drug mifepristone. The decision follows a multi-year shareholder and advocacy effort on the part of AMAC Action in conjunction with the Alliance Defending Freedom and Inspire Investing.

In August 2024, AMAC Action launched a direct member engagement campaign urging Costco’s top executives to reject any plans to offer mifepristone in their pharmacies. In less than two weeks, AMAC members sent more than 430 individual messages to each of four key Costco leadership offices, signaling widespread opposition to the company’s potential involvement in abortion drug distribution.

One year later, that effort has borne fruit, as Bloomberg recently reported that Costco had quietly decided against selling the drug, citing a “lack of consumer demand.”

“This is a huge victory for the AMAC membership and for every American who believes that businesses should steer clear of the abortion industry,” said AMAC Action Senior Vice President Andy Mangione. “It shows once again that when our members speak up, corporate America listens.”

The campaign against Mifepristone was rooted in both moral and safety concerns. According to FDA data, 1 in 25 women who take mifepristone require emergency care, and more than seven percent need surgery to complete the abortion. With several states already banning the drug and others actively challenging its legality, AMAC members called on Costco to avoid entangling itself in an issue that carries serious medical, legal, and ethical risks.

The Costco decision is part of a broader pattern of corporate accountability victories in which AMAC members have played a decisive role. In 2023 and 2024, AMAC helped secure changes at JPMorgan Chase following revelations of ideological discrimination, and earlier this year, members helped push IBM to adopt a viewpoint-neutral policy on media and advertising.

“These aren’t isolated wins,” said Mangione. “They’re proof that our members are helping build an economy that respects traditional American values and rejects the radical agendas being pushed by liberal ideologues in corporate HR offices.”

As more companies face pressure from activist investors and ideological interest groups, AMAC Action continues to stand as a powerful counterweight, mobilizing members to fight for transparency, neutrality, and common sense.

“Corporate activism cuts both ways,” Mangione added. “We will continue to shine a light on companies that go woke – and we’ll keep winning when we do.”

AMAC Action remains committed to defending life, protecting consumers, and holding corporations accountable to the values shared by millions of American seniors and families.